Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies

Figure 1

Characteristics significantly associated with anti-MDA-5-Ab-positive status.